← Back to Search

MOON+ for Opioid Use Disorder

N/A
Waitlist Available
Led By Traci C Green, PhD, MSc
Research Sponsored by Brandeis University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
English speaking, age 18 years or older, a pharmacist or pharmacy manager employed half time or more by CVS Pharmacy in Massachusetts or New Hampshire or by Albertsons Companies in Washington or Oregon
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months post intervention
Awards & highlights

Study Summary

This trial will test whether training and equipping pharmacists to provide naloxone to patients using opioids will improve opioid safety and prevent adverse events. The study will be conducted in four states with varying laws on naloxone distribution.

Eligible Conditions
  • Opioid Use Disorder
  • Pharmacy
  • Patient Safety

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, six months post intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, six months post intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
12 month change in naloxone distribution rates from study pharmacies
12 month change in naloxone-related patient engagement in the pharmacy
6 month change in naloxone distribution rates from study pharmacies
+1 more
Secondary outcome measures
12 months pharmacist self-reported changes
6 month pharmacist self-reported changes
baseline pharmacist self-reported changes

Trial Design

1Treatment groups
Experimental Treatment
Group I: MOON+Experimental Treatment1 Intervention
MOON+ includes pharmacist online training on opioid safety and naloxone provision, academic detailing of the pharmacy, materials for use at the pharmacy, standardized overdose response safety protocols, and reminder tools for training reinforcement

Find a Location

Who is running the clinical trial?

Comagine HealthUNKNOWN
2 Previous Clinical Trials
2,003 Total Patients Enrolled
Oregon Health and Science UniversityOTHER
973 Previous Clinical Trials
6,845,579 Total Patients Enrolled
University of Rhode IslandOTHER
52 Previous Clinical Trials
21,741 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
RESPOND TO PREVENT: Stepwise Pharmacy Naloxone Study
2019. "RESPOND TO PREVENT: Stepwise Pharmacy Naloxone Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03545321.
~78 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top